Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Biopharma DealmakersBiopharma Dealmakers
VS
Charles River LaboratoriesCharles River Laboratories
Biopharma Dealmakers

Biopharma Dealmakers

4 Crinan Street, London, N1 9XW, GB

Last Update: 06/03/2026

View Profile
Between 750 and 799
https://www.nature.com/biopharmdeal
752/1000Fair

Biopharma Dealmakers – a Nature Research publication – showcases active partnering companies and their opportunities across the biopharma industry.

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:None
Subsidiaries:31
12-month incidents
0
Known data breaches
0
Attack type number
0
Charles River Laboratories

Charles River Laboratories

251 Ballardvale Street, Wilmington, Massachusetts, US, 01887

Last Update: 31/03/2026

View Profile
Between 750 and 799
http://criver.com
776/1000Fair

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of ou...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:14,867
Subsidiaries:2
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Biopharma Dealmakers

Biopharma Dealmakers

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Charles River Laboratories

Charles River Laboratories

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Biopharma Dealmakers in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Charles River Laboratories in 2026.

Incidents

Incident History - Biopharma Dealmakers (X = Date, Y = Severity)

Biopharma Dealmakers cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Charles River Laboratories (X = Date, Y = Severity)

Charles River Laboratories cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Biopharma Dealmakers

Biopharma Dealmakers

Incidents
No explicit notable incidents reported.
Charles River Laboratories

Charles River Laboratories

Incidents
No explicit notable incidents reported.

FAQ

Between Biopharma Dealmakers company and Charles River Laboratories company, which one has the best AI Cybersecurity Score ?
Between Biopharma Dealmakers company and Charles River Laboratories company, which one has experienced more cyber incidents in the past ?
Between Biopharma Dealmakers company and Charles River Laboratories company, which one has experienced more cyber incidents this year ?
Between Biopharma Dealmakers company and Charles River Laboratories company, which one has experienced at least one ransomware attack ?
Between Biopharma Dealmakers company and Charles River Laboratories company, which one has experienced at least one data breach ?
Between Biopharma Dealmakers company and Charles River Laboratories company, which one has experienced at least one targeted cyberattack ?
Between Biopharma Dealmakers company and Charles River Laboratories company, which one has experienced at least one vulnerability ?
Between Biopharma Dealmakers company and Charles River Laboratories company, which one holds the most compliance certifications ?
Between Biopharma Dealmakers company and Charles River Laboratories company, which one holds the fewest compliance certifications ?
Between Biopharma Dealmakers company and Charles River Laboratories company, which one has the most subsidiaries ?
Between Biopharma Dealmakers company and Charles River Laboratories company, which one has the largest number of employees ?
Between Biopharma Dealmakers and Charles River Laboratories, which company holds both SOC 2 Type 1 certifications ?
Between Biopharma Dealmakers and Charles River Laboratories, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Biopharma Dealmakers or Charles River Laboratories ?
Which company is PCI DSS compliant - Biopharma Dealmakers or Charles River Laboratories ?
Between Biopharma Dealmakers and Charles River Laboratories, which company complies with HIPAA regulations for healthcare data ?
Between Biopharma Dealmakers and Charles River Laboratories, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-61246
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60455
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60439
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60373
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60372
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
REFERENCES